Liminatus Pharma, Inc. (LIMN)
NASDAQ:LIMN
Liminatus Pharma (LIMN) Ownership Overview
0.27% Mutual Funds
0.03% Other Institutional Investors
0.13% ETFs
99.58% Public Companies and
Individual Investors
The ownership structure of Liminatus Pharma (LIMN) stock is a mix of institutional, retail, and individual investors. Approximately 0.42% of the company’s stock is owned by Institutional Investors, and 99.58% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 100,000 | Institution | 0.38% | 948,000 | |
| 54,319 | Institution | 0.14% | 13,417 | |
| 50,440 | Institution | 0.13% | 12,459 | |
| 50,440 | Institution | 0.13% | 12,459 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 54,319 | Institution | 0.14% | 13,417 | |
| 50,440 | Institution | 0.13% | 12,459 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 50,440 | Institution | 0.13% | 27,752 |
FAQ
Who Owns Liminatus Pharma, Inc. (LIMN)?
Currently, no data Available
What percentage of Liminatus Pharma, Inc. (LIMN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.03% of Liminatus Pharma, Inc. (LIMN) stock is held by institutional investors.
What percentage of Liminatus Pharma, Inc. (LIMN) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.58% of Liminatus Pharma, Inc. (LIMN) stock is held by retail investors.
Who owns the most shares of Liminatus Pharma, Inc. (LIMN)?
Louis Moore Bacon owns the most shares of Liminatus Pharma, Inc. (LIMN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.